PTC Therapeutics Inc
PTCT
$65.28-0.14%
End of day · as of Sep 21, 2026, 4:15 PM ET
Mkt cap
$6.51B
EV/Sales
3.36
P/E ratio
N/A
FY2025 Revenue
$1.73B
EPS (TTM)
$-0.61
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
39.44%
Beta
N/A
Div yield
N/A
Sector
Healthcare
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported PTCT revenue for 2025-12-31 was $1.73B. Net income was $682.6M. Revenue was up 114.5% from 2024-12-31 to 2025-12-31. PTCT currently screens at market cap $6.51B.
Use this PTCT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PTCT income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
PTC Therapeutics Inc (PTCT) is a biotechnology company in the Healthcare sector.
Latest cached PTC Therapeutics Inc (PTCT) revenue for Dec 31, 2025 was $1.73B. Net income was $682.6M. Statements: https://lician.com/financials/ptct
PTC Therapeutics Inc (PTCT) market capitalization is $6.51B on the latest cached snapshot.
PTC Therapeutics Inc (PTCT) cached previous close $65.37; day range $64.99 – $66.21; volume 737,910. Session quote: https://lician.com/quote/ptct
PTC Therapeutics Inc (PTCT) latest cached earnings event is "PTCT earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PTCT filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/ptct